Skip to main navigation

News & Events Publications Patient Resources Contact
  • About Us
    • Leadership
    • Board
    • Scientific Advisors
    • Careers & Culture
    • Open Opportunities
  • Science
    • HBV Assets
      • Imdusiran (AB-729)
      • AB-101
  • Pipeline
  • Partnering
  • >
  • Investors
    • Investor Center
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Investor FAQ
    • Contact Us
  • Culture & Careers

Investor Relations

  • Investor Center
  • Stock Information
  • Financial Information
  • Corporate Governance
  • Press Releases
  • Events & Presentations
  • Investor FAQ
  • Contact Us

Events & Presentations

Arbutus Tender Offer

Aug 24 - Sep 29, 2026

Supporting Materials

Schedule TO-I 43.3 KB
Offer to Purchase dated August 24 2026 together with the Issuer Bid Circular 367.2 KB
Form of Letter of Transmittal (including IRS Form W-9 and Form NR-301) 376.5 KB
Form of Notice of Guaranteed Delivery 68.1 KB
Letter to Brokers Dealers Banks Trust Companies and Other Nominees 64.6 KB
Letter to Clients for Use by Brokers Dealers Banks Trust Companies and Other Nominees 82.6 KB
Frequently Asked Questions for Employees dated August 24 2026 39.1 KB
Instructions to Shareworks Participants 26.8 KB
Material Change Report dated August 24 2026 230.6 KB
Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share 105.3 KB
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer 22.5 KB

Back to previous page

Shareholder Tools

  • Email Alerts Email Alerts
  • RSS News Feeds RSS News Feeds
  • Download Library Download Library

© 2026 Arbutus Biopharma

Legal Terms